快讯：OpenAI 推出面向生物医学的 GPT-Rosalind；2027 年总统大选预算中包含 AI；Perplexity 揭示其个人电脑（Personal Computer）代理（agent）
Telex : OpenAI lance GPT-Rosalind pour le biomédical, L'IA incluse dans les dépenses de la présidentielle 2027, Perplexity dévoile son agent Personal Computer
法国科技媒体 Telex 报道：OpenAI 发布面向生物医学的 GPT-Rosalind，用于加速医疗与科研相关的文本理解/生成；同时，法国总统选举 2027 的预算中将纳入“AI（含相关投入）”。此外，Perplexity 推出其代理型产品 Personal Computer，强调以智能体方式提升个人电脑场景的自动化与生产力，可能推动生物医药与通用AI代理应用的落地速度。
该文章仅爬取到标题，未获取到正文内容。
查看原文OpenAI has launched GPT-Rosalind, a biomedical-focused GPT model aimed at accelerating work in healthcare and life sciences. The article also notes that AI is being incorporated into France’s 2027 presidential spending plans, while Perplexity unveiled “Personal Computer,” an AI agent designed to help users perform tasks on their devices—potentially shifting how people interact with software and productivity tools.
Only the headline was crawled; full content was not available.
Read originalOpenAI lance GPT-Rosalind, une nouvelle IA dédiée au biomédical, tandis que la France prévoit d’intégrer l’IA dans les dépenses de la présidentielle 2027. De son côté, Perplexity dévoile Personal Computer, un agent conçu pour assister les utilisateurs comme un “ordinateur” personnel, ce qui renforce l’automatisation et l’usage opérationnel de l’IA dans des contextes concrets.
Seul le titre a été récupéré.
Lire l'originalCore Point
OpenAI launched GPT-Rosalind for biomedical use, while France’s 2027 presidential budget reportedly includes AI spending and Perplexity unveiled an “Personal Computer” agent—together signaling faster AI commercialization across healthcare, policy, and consumer productivity.
Key Players
OpenAI — builds frontier AI models; US-based.
Perplexity — AI search/assistant company launching an agentized “Personal Computer”; US-based.
Industry Impact
- Computing/AI: High — new biomedical foundation model plus agentic “PC” direction accelerates applied AI deployment.
- ICT: Medium — increased AI funding and agent tooling likely drives enterprise adoption and vendor demand.
- Energy: Low — no direct energy signal beyond indirect compute demand.
Tracking
[Strongly track] — biomedical model readiness and Perplexity’s agentized “PC” could quickly shift workflows and competitive dynamics.